A rater-blinded, exploratory, tolerability and efficacy study of sodium oxybate (xyrem) in patients with treatment-refractory hyperkinetic movement disorders

被引：0
|
作者：
Frucht, S. J.
Bordelon, Y.
Greene, P. E.
Floyd, A.
Pullman, S.
Louis, E. D.
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA
来源：
MOVEMENT DISORDERS | 2006年 / 21卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1554 / 1554
页数：1
相关论文
共 50 条
  • [1] Sodium oxybate (Xyrem) in treatment-refractory byperkinetic movement disorders
    Frucht, S. J.
    Bordelon, Y.
    Greene, P. E.
    Floyd, A.
    Pullman, S.
    Louis, E. D.
    MOVEMENT DISORDERS, 2006, 21 : S636 - S636
  • [2] The tolerability and efficacy of sodium oxybate (Xyrem®) as a treatment for ethanol-responsive, medication-refractory myoclonus and essential tremor (ET)
    Frucht, SJ
    Houghton, WC
    Bordelon, Y
    Louis, ED
    Greene, PE
    MOVEMENT DISORDERS, 2005, 20 (09) : 1240 - 1240
  • [3] A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders
    Frucht, SJ
    Bordelon, Y
    Houghton, WH
    Reardan, D
    MOVEMENT DISORDERS, 2005, 20 (10) : 1330 - 1337
  • [4] Effectiveness and tolerability of pregabalin for dystonia and other hyperkinetic movement disorders (HMDs): An open-label exploratory study
    Swope, D. M.
    Chen, J. J.
    MOVEMENT DISORDERS, 2006, 21 : S385 - S386
  • [5] Long-term efficacy and tolerability of quetiapine in treatment-refractory schizophrenia: A case study
    Reznik, I
    Benatov, R
    Sirota, P
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 : 16 - 16
  • [6] Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
    Lee, Seung-Hoon
    Jeon, Sang Won
    Shin, Cheolmin
    Pae, Chi-Un
    Patkar, Ashwin A.
    Masand, Prakash S.
    An, Hyonggin
    Han, Changsu
    PSYCHIATRY INVESTIGATION, 2022, 19 (04) : 268 - 280
  • [7] A Multicenter, Parallel-group, Rater-blinded, Randomized Clinical Study Investigating the Efficacy, Safety and Tolerability of 2 Dosing Regimens of ND0612
    Poewe, Werner
    Stocchi, Fabrizio
    Simuni, Tatyana
    Ellenbogen, Aaron
    Leionen, Mika
    Rachmilewitz, Tami
    Case, Ryan
    Kieburtz, Karl
    Olanow, C. Warren
    MOVEMENT DISORDERS, 2018, 33 : S92 - S93
  • [8] Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study
    Bai, Hua
    Wang, Wen-Hui
    Zhou, Fan-Fan
    Yang, Dan
    Li, Rui-Jun
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 73 - 86
  • [9] Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders
    Glue, Paul
    Neehoff, Shona M.
    Medlicott, Natalie J.
    Gray, Andrew
    Kibby, Guy
    McNaughton, Neil
    JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (06) : 663 - 667
  • [10] Long-term treatment with supraphysiologic doses of levothyroxine in treatment-refractory mood disorders - A prospective study of cardiovascular tolerability
    Pilhatsch, Maximilian
    Berghoefer, Anne
    Mayer-Pelinski, Rene
    Berghoefer, Gunnar
    Ricken, Roland
    Moeckel, Martin
    Kuehnle, York
    Sauer, Cathrin
    Whybrow, Peter C.
    Bauer, Michael
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 238 : 213 - 217
12345